Product image of Narox (Etoricoxib) supplied by GNH India

Narox

Active Ingredient:
Etoricoxib
Origin:
EU

Narox (Etoricoxib)

Etoricoxib, the active ingredient in Narox, is a COX-2 selective NSAID presented as a tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, gout and other musculoskeletal conditions in adults.

GNH India supplies Narox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Delorbis Pharmaceuticals Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Etoricoxib is indicated for inflammatory joint disorders and acute gout flares, providing analgesic and anti‑inflammatory effects.

  • Osteoarthritis: reduces joint pain and improves mobility.
  • Rheumatoid arthritis: decreases inflammation and slows disease‑related joint damage.
  • Gout: relieves acute gouty arthritis pain and swelling.

How It Works

  • Etoricoxib selectively inhibits the cyclooxygenase‑2 (COX‑2) enzyme, which blocks the conversion of arachidonic acid to prostaglandins responsible for inflammation, pain, and fever. By sparing COX‑1 activity, it aims to maintain gastric mucosal protection while providing anti‑inflammatory and analgesic benefits.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Gastrointestinal discomfort: dyspepsia or abdominal pain.
  • Hypertension: increase in blood pressure readings.
  • Dizziness: transient sensation of light‑headedness.

Serious or Rare Side Effects

  • Cardiovascular thrombotic events: myocardial infarction or stroke.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Gastrointestinal ulcer or bleeding: may occur without warning.
  • Renal impairment: acute kidney injury or worsening of chronic kidney disease.
  • Hepatic injury: elevated liver enzymes or hepatitis.

Precautions & Warnings

Before prescribing Etoricoxib, clinicians should evaluate patient‑specific risk factors and monitor therapy.

  • Cardiovascular risk assessment: avoid in patients with uncontrolled hypertension or recent thrombotic events.
  • Blood pressure monitoring: check regularly during treatment.
  • Renal and hepatic function: adjust use in patients with impairment.
  • Hypersensitivity review: discontinue if allergic reactions develop.
  • Concomitant anticoagulant use: monitor for increased bleeding risk.
  • Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Etoricoxib may interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased bleeding risk.
  • Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and cardiovascular toxicity.
  • CYP2C9 inhibitors (e.g., fluconazole): elevated Etoricoxib plasma levels.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or diuretics: possible reduction in antihypertensive effect.
  • Lithium: risk of lithium toxicity.
  • Methotrexate: potential for increased methotrexate toxicity.
  • Antihypertensive agents: may require dose adjustment.

Frequently Asked Questions

Narox contains Etoricoxib, a COX‑2 selective NSAID prescribed for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and acute gout attacks. It helps improve joint function and reduces swelling in these musculoskeletal disorders.

Etoricoxib works by selectively blocking the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for producing prostaglandins that cause inflammation, pain, and fever. By inhibiting COX‑2 while sparing COX‑1, it reduces inflammatory mediators without markedly affecting gastric protection.

The dosage of Narox is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and overall health status. Healthcare professionals tailor the dose to achieve optimal pain control while minimizing potential risks.

Safety data for Etoricoxib in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Narox, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with non‑selective NSAIDs, Etoricoxib offers COX‑2 selectivity, which may reduce the risk of gastrointestinal irritation while still providing effective analgesia. However, it shares cardiovascular risk considerations common to the NSAID class, so patient selection remains important.

Narox should be stored at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain product stability.

Narox is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber to ensure consistent absorption.

Serious risks include cardiovascular events such as heart attack or stroke, severe skin reactions like Stevens‑Johnson syndrome, gastrointestinal ulceration or bleeding, and potential renal or hepatic impairment. Patients should be monitored closely for any signs of these conditions.

Narox is contraindicated in individuals with known hypersensitivity to Etoricoxib or other COX‑2 inhibitors, those with active cardiovascular disease, uncontrolled hypertension, severe liver or kidney impairment, and patients who have experienced serious gastrointestinal bleeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Etoricoxib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT